Pomelo Care, a virtual maternity and women’s health company, has raised $92 million in Series C funding at a $1.7 billion valuation. The round was led by Stripes with participation from Andreessen Horowitz, PLUS Capital, Atomico, BoxGroup, and SV Angel.
The New York-based company, founded in 2021, now covers more than 25 million lives through partnerships with health plans and employers, representing nearly 7% of U.S. births. Pomelo will use the funding to expand its maternity care model and extend into women’s and children’s health across additional life stages, including reproductive care, pediatrics, and menopause.
“Pomelo Care was founded to measurably improve maternal health in the United States,” said Marta Bralic Kerns, founder and CEO of Pomelo Care. “We’ve demonstrated that when care is proactive, evidence-based, and accountable, we improve outcomes and costs come down. Now, with this funding, we’re taking that proven model beyond maternity to build a system of care that supports women and children throughout their lives, delivering better results across the entire healthcare ecosystem—for patients, payers, providers, and employers alike.”
Pomelo delivers 24/7 virtual care through a team that includes nurses, dietitians, therapists, doulas, and providers. The company has published peer-reviewed, claims-based outcomes showing a 37% reduction in preterm births, a 6.8-day reduction in NICU length of stay, a 46% reduction in emergency room utilization, and 718% higher prenatal depression screening and follow-up rates. The company reports a 3-5x ROI for customers.
The company recently launched a midlife care program addressing perimenopause and menopause. Early results show an 88% reduction in symptoms measured by the Menopause Rating Scale within 60 days, and 73% of patients reporting increased productivity after joining the program.
“We are thrilled to double down on our partnership with Pomelo and are proud to support Marta and the entire Pomelo team on their mission to build a category-leading business in women’s and children’s healthcare,” said Ron Shah, Partner at Stripes. “Pomelo has reached national scale at an unprecedented rate — now serving 25 million covered lives through Commercial and Medicaid health plan partnerships across the United States. The power of Pomelo’s amazing product is clear: exceptional patient satisfaction and strong clinical results showing meaningful reductions in pregnancy-related complications. We believe Pomelo’s intelligent care platform will power continued rapid growth and product expansion, meeting rising demand from patients and payers with a modern clinical experience and best-in-class operating metrics.”
